CBP/p300-IN-3
Product Specifications
UNSPSC Description
CBP/p300-IN-3, a p300/CBP histone acetyltransferase inhibitor, Compound 6, is sourced from patent WO 2019049061 A1[1].
Target Antigen
Histone Acetyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/p300-cbp-in-3.html
Purity
98.95
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=C2C(N=C(C3=CC=C(N(CC)CC)N=C3)N2CC4=NN(CC)C=C4)=C1)NC
Molecular Weight
431.53
References & Citations
[1]Medina, et al. 5-(1H-Benzo[d]imidazol-2-yl)pyridin-2-amine and 5-(3H-imidazo[4,5-b]pyridin-6-yl)pyridin-2-amine derivatives as c-MYC and p300/CBP histone acetyltransferase inhibitors for treating cancer and their preparation.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-128876/CBP-p300-IN-3-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-128876/CBP-p300-IN-3-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2299226-01-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
